New capabilities available to benefit Artificial Intelligence (AI) Model Developers, Health Systems, Life Science Organizations and Data Holders announced today. In addition to partnership with QuantHealth, Atropos Health is advancing the development of technology by making it easier and faster to deploy and test technology in healthcare. Here’s more detail on how these partners can benefit from these features and membership in the Atropos Evidence Network:
For AI Developers: Technology builders seeking to engage with data to advance healthcare can test their AI/ML/LLM/NLP tool/application on the high-quality real-world data (RWD) available in the Atropos Evidence Network.
- Lower the cost of entry and avoid a single big data purchase and instead access a large and growing asset
- Train your model with data assurance at the forefront; test for and detect bias from the start
- Access a network of member institutions and life science companies to distribute your models to
For Health Systems: Clinicians, researchers, internal development teams and health system executives seeking evidence-based insights they can’t otherwise find in published literature and can’t wait weeks or months to receive, can find answers from RWD sources on the Atropos Evidence Network when local data is not enough or not available.
- Test your home grown/in-house developed AI models on the largest federated data network, maintaining control of the results
- Deploy AI models from other vendors without shipping your data, keeping control over data use permissions. Retain your data locally.
- Benefit from a passive revenue stream by permitting certain use of your anonymized data asset
For Life Sciences Organizations: HEOR, Medical Affairs, and Research and Development teams benefit from building testing and training models that reduce the time from symptom to testing to treatment.
- Build and test AI models on your own internal data with GENEVA OS™ installed inside your firewall and on external data from the Atropos Evidence Network
- Test the transferability of your model
- Release your AI model via the Atropos Health network of partners for a turnkey deployment solution that meets compliance standards and provides robust reporting
For Data Partners: RWD holders now have an objective measure of their data quality that can enhance and extend the value of a dataset.
- Objectively measure and benchmark your data quality based on your Data Quality Score Card, provided to every data holder in the Atropos Evidence Network. The methodologies for data scoring are transparent and published.
- Enhance your dataset by adopting the recommendations provided in the Data Quality Score Card
- Maintain control of data use rights
- Benefit from a federated network. With GENEVA OS, your data isn’t shipped or transferred. You maintain possession.
- Earn passive revenue. Benefit financially when you permit AI developers to test and train on the data you hold.